MARTIN SIGNS UP TO COLLECT STOCK PURCHASE WARRANTS AND RESTRICTED STOCK, FROM A ’34 ACT REPORTING COMPANY… IN ARGUABLE VIOLATION OF HIS CRIMINAL CONVICTION ORDERS(?). WILD.

So… after he “lost” 100% of his (likely mythical) trading portfolio in a single day — betting stupidly on a short that blew upward by 360% (also in a single day, liquidating his position on a supposed margin call)… he says he’s back as a “consultant” and connector — to a optical computing R&D company.

Which would be fine… if Q/C Technologies, Inc. was a private company.

But it is a ’34 Act reporting company — it is a PUBLIC company, traded on the NASDAQ. Moreover, it has been working on commercialization of two therapeutic platforms based on well-defined targets: Isomyosamine and Supera-CBD.

It sum, it is a life-sciences focused (potentially FDA regulated) medical pot / drug discovery company [until just about two months ago, that is]. That reads directly on his FTC lifetime banning order, affirmed by the US Supreme Court in 2024.

In addition to being paid $150,000 cash a year, he will earn stock purchase warrants, and restricted stock.

Moreover, as I understand his FTC banning order’s resolution (including accepting a agreed settlement of the over $12 million he owed in fines and penalties and expense reimbursement to the FTC, SEC and the US Attorneys offices in Brooklyn), he agreed never to accept a role, for pay — at any public company doing pharma work… and, at least NOT payable in the securities of a public company. Ever.

I’ll be back with some more specific citations (to his court ordered terms), but this is just… Stoopid, with two “Os”.

Even if the company does actually “FLIP” — to solely a optical computing developer, it still is closing out a… pharma biz. He cannot be around for that, for any type of pay.

[Meanwhile, he is still paying Dr. Koestler’s lawyers month by month to continue to try to chase him for the now-nearly $8 million he owes under federal court judgments, to the Estate of Koestler (Deceased).]

Damn. Out.

नमस्ते